Guava Aims to Make Cell Analysis Affordable: How Does it Compare? | GenomeWeb

When it comes to cellular analysis systems, high throughput is not the only consideration. For many researchers low cost, small size, and ease of use may be just as important.

Recognizing this inclination, Guava Technologies of Hayward, Calif., has built its business around its Personal Cell Analysis (PCA) and PCA-96 platforms — automated fluorescent-based cellular analysis systems that fit onto a laboratory bench top and don't empty researchers' wallets.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.